| NCT07355010 | Qinglei Gao | Ovarian Cancer | 2025-12-30 | PHASE2 |
| NCT07478731 | Hong Qiu | CRC (Colorectal Cancer) | 2025-12-20 | PHASE2 |
| NCT03774979 | Jiangsu HengRui Medicine Co., Ltd. | Solid Tumor | 2019-01-24 | PHASE1 |
| NCT07175220 | Jiangsu HengRui Medicine Co., Ltd. | Locally Advanced or Metastatic Non-small Cell Lung Cancer | 2025-10-09 | PHASE2 |
| NCT05896046 | Chinese PLA General Hospital | Relapsed or Refractory Hodgkin Lymphoma | 2023-06-14 | PHASE1|PHASE2 |
| NCT07102901 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Gastric Cancer|Metastatic Gastric Cancer|Gastroesophageal Junction Adenocarcinoma | 2025-09-05 | PHASE2 |
| NCT04560244 | Shandong Cancer Hospital and Institute | Non-Small-Cell Lung Cancer | 2020-09 | PHASE2 |
| NCT04282070 | Jiangsu HengRui Medicine Co., Ltd. | Nasopharyngeal Carcinoma | 2020-03-27 | PHASE1 |
| NCT03710265 | Jiangsu HengRui Medicine Co., Ltd. | Solid Tumor | 2018-11-20 | PHASE1 |
| NCT07384234 | Ruijin Hospital | Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | 2026-01-31 | PHASE2 |
| NCT05149807 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer | 2022-01-26 | PHASE2|PHASE3 |
| NCT06679673 | Fudan University | Colorectal Cancer Metastatic | 2024-12 | PHASE2 |
| NCT07451795 | Fudan University | Prostate Cancer|mCRPC (Metastatic Castration-resistant Prostate Cancer) | 2026-03-02 | PHASE2 |
| NCT04679038 | Jiangsu HengRui Medicine Co., Ltd. | Solid Tumor | 2021-03-17 | PHASE1|PHASE2 |
| NCT05198817 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Malignant Tumors | 2022-02-22 | PHASE1 |
| NCT04884009 | Jiangsu HengRui Medicine Co., Ltd. | Lung Cancer | 2021-05-31 | PHASE2 |
| NCT04580498 | Jiangsu HengRui Medicine Co., Ltd. | Non-Small-Cell Lung Cancer | 2020-11-10 | PHASE2 |
| NCT07517653 | Shanghai Zhongshan Hospital | Melanoma | 2026-04-01 | PHASE2 |
| NCT07147088 | Fudan University | Advanced Intrahepatic Cholangiocarcinoma | 2025-09-01 | PHASE2 |
| NCT07294664 | The First Affiliated Hospital of Zhengzhou University | Advanced Gastric Cancer|SHR1701 | 2025-06-15 | PHASE2 |
| NCT04355858 | Fudan University | Breast Cancer|Metastatic Cancer | 2020-05-01 | PHASE2 |
| NCT07311408 | Jingdong Zhang | Gastric Cancer (GC)|Gastroesophageal Junction Adenocarcinoma | 2026-01-01 | PHASE2 |
| NCT05132413 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer | 2021-12-30 | PHASE3 |
| NCT04699968 | Jiangsu HengRui Medicine Co., Ltd. | Non-Small-Cell Lung Cancer | 2021-01-15 | PHASE2 |
| NCT04324814 | Atridia Pty Ltd. | Advanced Solid Tumor | 2020-03-31 | PHASE1 |
| NCT07503639 | Fudan University | Locally Advanced Colorectal Cancer | 2026-04 | PHASE2 |
| NCT05106023 | Yong Chen | Melanoma | 2022-01-21 | PHASE2 |
| NCT04624217 | Jiangsu HengRui Medicine Co., Ltd. | Pancreatic Cancer | 2020-11-24 | PHASE1|PHASE2 |
| NCT05020925 | Jiangsu HengRui Medicine Co., Ltd. | Nasopharyngeal Carcinoma | 2021-09 | PHASE1|PHASE2 |
| NCT04407741 | Chinese PLA General Hospital | Solid Tumor|Lymphoma | 2020-09-01 | PHASE1|PHASE2 |
| NCT04937972 | Hunan Province Tumor Hospital | Non-Small Cell Lung Cancer | 2021-07-01 | PHASE2 |
| NCT05671822 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | HER2 Expression Gastric Cancer+Gastroesophageal Junction Adenocarcinoma | 2023-03-14 | PHASE2 |
| NCT04650633 | Jiangsu HengRui Medicine Co., Ltd. | Squamous Cell Carcinoma of Head and Neck | 2021-05-07 | PHASE2 |
| NCT06893887 | Nanjing Tianyinshan Hospital | Hepatocellular Carcinoma(HCC) | 2025-05-22 | NA |
| NCT06881017 | China Medical University, China | Gastric Cancer|HER2 &addition; Gastric Cancer|CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction|PD-L1 Positive | 2025-05-01 | PHASE2 |
| NCT07464756 | The First Affiliated Hospital with Nanjing Medical University | Gastric Adenocarcinoma | 2026-04-05 | PHASE2 |
| NCT07493382 | Tianjin Medical University Cancer Institute and Hospital | GEJ Adenocarcinoma | 2026-04-01 | NA |
| NCT07567326 | Peking University Cancer Hospital & Institute | Non Small Cell Lung Cancer | 2026-07 | PHASE2 |
| NCT07550920 | Tianjin Medical University Cancer Institute and Hospital | NSCLC | 2026-05-10 | PHASE2 |